Home » High Cholesterol

High Cholesterol

by admin

References & Resources

  1. Cholesterol at the US National Library of Medicine Medical Subject Headings(MeSH). http://www.nlm.nih.gov/mesh/. Accessed April 25, 2013.
  2. Hanukoglu I. “Steroidogenic enzymes: structure, function, and role in regulation of steroid hormone biosynthesis.” J Steroid Biochem Mol Biol. 1992;43(8):779–804
  3. Jensen RG, et al. Lipids of human milk and infant formulas: a review. Am J ClinNutr. 31 (6): 990–1016.
  4. Triglycerides. http://www.heart.org/HEARTORG/GettingHealthy/NutritionCenter/Triglycerides_UCM_306029_Article.jsp. Accessed on April 26, 2013.
  5. Huffman KM, et al. Exercise effects on lipids in persons with varying dietary patterns – does diet matter if they exercise? American Heart Journal. 2012;164:117.
  6. Chapman MJ, et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: Evidence and guidance for management. European Heart Journal. 2011;32:1345.
  7. What is cholesterol? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/hbc/. Accessed April 24, 2012.
  8. About Cholesterol. http://www.heart.org/HEARTORG/Conditions/Cholesterol/Cholesterol_UCM_001089_SubHomePage.jsp. Accessed on April 24, 2013.
  9. National Cholesterol Education Program. Third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. NIH Pub. No. 02-5215. Bethesda, MD: National Heart, Lung, and Blood Institute, 2002;284 pages.
  10. Institute of Medicine. Secondhand Smoke Exposure and Cardiovascular Effects: Making Sense of the Evidence. Washington, D.C.: National Academies Press; 2009.
  11. Cholesterol. http://www.cdc.gov/cholesterol/what_you_can_do.htm. Accessed on April 18, 2013.
  12. National Cholesterol Education Program. Third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. NIH Pub. No. 02-5215. Bethesda, MD: National Heart, Lung, and Blood Institute, 2002; 284 pages.
  13. Lichtenstein AH, et al. American Heart Association Nutrition Committee. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114:82-96.
  14. Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, Dolor RJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 2007;115:1481-1501.)
  15. Slentz CA, Houmard JA, Johnson JL et al. Inactivity, exercise training and detraining, and plasma lipoproteins. STRRIDE: a randomized, controlled study of exercise intensity and amount. J Appl Physiol. 2007 Aug;103(2):417-8.
  16. Powers E, Saultz J, Hamilton A, et al. Clinical inquiries. Which lifestyle interventions effectively lower LDL cholesterol? J Fam Pract. 2007 Jun;56(6):483-5.
  17. National Cholesterol Education Program. Third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. NIH Pub. No. 02-5215. Bethesda, MD: National Heart, Lung, and Blood Institute, 2002;284 pages.
  18. Crestor Prescribing Information, U.S. Food and Drug Administration, Full Prescribing Information, Published February 2012; Reference ID: 3094421.
  19. Stein EA. Comparison of Statins in Hypertriglyceridemia. Am J Cardiol.1998;81(4A):66B–69B.
  20. Holmes CL, et al. Angiographic results of lipid-lowering trials: a systematic review and meta-analysis. In: Grundy SM, ed. Cholesterol-lowering therapy: evaluation of clinical trial evidence. New York: Marcel Dekker Inc., 2000:191-220.
  21. Vytorin. http://www.rxlist.com/vytorin-drug.htm. Accessed on April 24, 2013.
  22. Gotto AM, Jr. Safety and statin therapy: Reconsidering the risks and benefits. Arch Intern Med. 2003;163:657-659.
  23. Miettinen TA. Diurnal variation of cholesterol precursors squalene and methyl sterols in human plasma lipoproteins. Journal of Lipid Research. 1982;23 (3): 466–7.
  24. Bile. National Institute of Health. http://www.nlm.nih.gov/medlineplus/ency/article/002237.htm. Accessed on May 3, 2013.
  25. Greenhalgh RM and Powell JT. Endovascular repair of abdominal aortic aneurysm. N Engl J Med. 2008;358:494-501.
  26. Jenkins DJA. Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. Am J Clin Nutr. 2002;75:834–9.
  27. CholestOff®. http://www.naturemade.com/products/segments/cholestoff. Accessed on Aprtil 26, 2013.
  28. Jones PJ, Raeini-Sarjaz M, Ntanios F, et al. modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J Lipid Res. 2000;41:697–705.
  29. Herbs a quick guide to herbal supplements at a glance. National Institutes of Health. National Center for Complementary and Alternative Medicine. Accessed on April 24, 2013.
  30. Scientific Opinion on the substantiation of a health claim related to barley beta-glucans and lowering of blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006.
  31. Khawaja O, et al. A meta-analysis of omega-3 fatty acids and incidence of atrial fibrillation. J Am Coll Nutr. 2012;31:4-13.
  32. Lovaza. http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm186892.htm. Accessed on April 24, 2013.
  33. Erdman JW. A Statement for Healthcare Professionals from the Nutrition Committee of the AHA. http://circ.ahajournals.org/content/102/20/2555.1.full. Accessed on April 25, 2013.

Was this Content Helpful?

Related Articles